Skip to main content
. 2021 May 6;4(5):e215731. doi: 10.1001/jamanetworkopen.2021.5731

Figure 3. Findings by Drug Pair of Randomized Clinical Trials Directly Comparing Single-Enantiomer and Racemic Drug Pairs for Safety End Points.

Figure 3.